Doxorubicin synergises with a TRAIL-R1-specific ligand to selectively target TRAIL-resistant breast tumour cells for apoptosis

✍ Scribed by Shambhavi Naik; Davina Twiddy; Roshna Mistry; Jennifer M. Edwards; Gerald M. Cohen; Rosemary A. Walker; Marion MacFarlane

• Book ID: 113934077
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 109 KB
• Volume: 290
• Category: Article
• ISSN: 0300-483X
• DOI: 10.1016/j.tox.2011.09.071